Skip to main content

Year: 2025

VCI Global Partners with Oobit to Expand Access to the US$3.1 Trillion Global Payment Market for Crypto-to-Fiat Transactions

Voobit to Launch as a Next-Generation Rail Enabling Merchants to Receive Instant Fiat Settlement From USDT, Bitcoin and Ethereum Payments Without Intermediaries KUALA LUMPUR, Malaysia, Nov. 25, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced a strategic partnership with Oobit, a global digital payment enabler, to expand access to the global payment market through new crypto-to-fiat settlement infrastructure. The collaboration will enable digital-asset payments with instant fiat conversion for merchants across ASEAN and other high-growth emerging markets. Oobit’s platform, already live in multiple regions, allows consumers to pay using USDT, Bitcoin, Ethereum, OOB, and other major digital assets, while merchants receive real-time fiat settlement in their preferred local currencies....

Continue reading

Evolution and Galaxy Gaming Extend Merger Agreement as Acquisition Progresses; Remaining Regulatory Approvals are Anticipated in Q1 2026

With Mississippi approval secured, only two pre-close jurisdictions remain LAS VEGAS, Nov. 25, 2025 (GLOBE NEWSWIRE) — As previously announced, Galaxy Gaming, Inc.® (OTC: GLXZ) (“Galaxy” or the “Company”), the world’s leading independent developer and distributor of casino table games and technology, Evolution Malta Holding Limited, a company registered in Malta (“Evolution”), and Galaga Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Evolution, entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Merger Sub will be merged with and into Galaxy, with Galaxy surviving as a wholly owned subsidiary of Evolution (the “Merger”). Evolution and Galaxy Gaming today announced that they have mutually agreed to extend the Merger Agreement “outside date” through July 17, 2026, reaffirming...

Continue reading

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapyIRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic solutions, is proud to announce that its inFoods® IBS diagnostic-guided therapy product is being featured in the Fall 2025 issue of Biotherapeutics Quarterly, a Henry Schein publication. The article, titled “Precision Medicine for IBS: A Novel, IBS-Specific Immune Response Guided Dietary Therapy”, presents comprehensive clinical and scientific insights into the company’s innovative approach to managing Irritable Bowel Syndrome (IBS). The publication details results from a randomized, multicenter, double-blind, placebo-controlled clinical trial evaluating...

Continue reading

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva’s biosimilars PONLIMSI and DEGEVMA expanding access to important bone health treatments across Europe These approvals mark another significant milestone in Teva’s strong biosimilars portfolio, in line with Teva’s Pivot to Growth Strategy The approvals underscore Teva’s commitment to broadening access to biosimilarsTEL AVIV, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) announced that the European Commission (EC) has granted marketing authorizations for its two denosumab biosimilar candidates – PONLIMSI, a biosimilar to Prolia®1 and DEGEVMA, a biosimilar...

Continue reading

Suspension i forbindelse med fusion

I forbindelse med fusion den 28. november 2025 af Investeringsforeningen Nordea Invest Engros Corporate Bonds og Investeringsforeningen Nordea Invest Virksomhedsobligationer KL 2, vil handelen i afdelingen Nordea Invest Virksomhedsobligationer KL herunder andelsklasse KL 1 og andelsklasse KL 2 blive suspenderet fra og med den 27. november 2025 til og med den 28. november 2025.ISIN DK0016015399Afdeling/andelsklasse Virksomhedsobligationer KL 1Suspenderingsdato 27. november 2025 – 28. november 2025Med venlig hilsenNordea Fund Management, filial af Nordea Funds Oy, Finland Rasmus Eske BruunFilialbestyrer

Continue reading

Nokia Canada breaks ground on new Ottawa innovation campus, helping to shape the future of Canadian Tech leadership

Press Release Nokia Canada breaks ground on new Ottawa innovation campus, helping to shape the future of Canadian Tech leadershipMajor investment cements Canadian leadership in AI, quantum, and next-generation connectivity while driving sustainable growth and world-class talent development Project showcases the strength of Nokia’s strategic partnerships with the Government of Canada, Government of Ontario and City of Ottawa.25 November 2025Ottawa, Canada – Today marks a bold new era for Canadian innovation as Nokia breaks ground on its next-generation Ottawa campus, reinforcing Canada’s position as a global leader in connectivity. Building on more than five decades of pioneering innovation in the Ottawa region, Nokia is reaffirming its leadership in the nation’s communications technology evolution. The new campus will play a pivotal...

Continue reading

Fusion Fuel’s BrightHy Solutions Expands Green Hydrogen Footprint in Southern Europe with Agreement to Deliver New Electrolyzer and Hydrogen Refueling Station Project

Dublin, Ireland, Nov. 25, 2025 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced that its subsidiary, Bright Hydrogen Solutions Ltd (“BrightHy Solutions”), a leading engineering and advisory company specialized in green hydrogen, has signed a definitive contract to be the engineering, installation and equipment provider for a green hydrogen project in southern Europe. This follows the Company’s September 2 press release, in which BrightHy Solutions announced it had been selected to negotiate this agreement. The contract, valued at up to approximately €1.7 million, covers the delivery of an electrolyzer system and hydrogen refueling station for a large construction company, supporting the...

Continue reading

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will host a virtual Analyst & Investor Day on Monday, December 1, 2025 at 10:00 AM ET, during which company management will highlight various aspects of BrainsWay’s growth strategy. The event will feature Owen Scott Muir, MD, DFAACAP (Co-Founder, Chief Medical Officer, Radial), who will discuss the significant unmet need for various conditions and his clinical experience utilizing Deep TMS™, and Michael Gershenzon, CEO of Stella MSO, a management services organization servicing more than 20 mental health clinics across the U.S. and Israel, who will discuss his experience working with...

Continue reading

Parsons to Present at Goldman Sachs Industrials and Materials Conference

CHANTILLY, Va., Nov. 25, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will participate in a fireside chat question and answer session at the Goldman Sachs Industrials and Materials Conference on Wednesday, December 3, 2025, at approximately 2:10 p.m. Eastern Time. The presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com). A replay of the webcast will be available on the website following the presentation for 30 days. About Parsons Corporation Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and electronic warfare,...

Continue reading

Dragonfly Energy Broadens Product Lineup to Drive Growth Beyond Batteries

Expanded Battle Born® portfolio introduces inverter/chargers, Base Series batteries, and a redesigned mobile app to deliver complete power system solutions RENO, Nev., Nov. 25, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced a major expansion of its Battle Born® product portfolio. The Company is introducing new inverter/chargers, Base Series batteries, and a redesigned mobile app, strengthening its position as a complete power solutions provider across off-grid, RV, marine, and commercial markets. The expansion includes the new Battle Born Inverter/Charger Series, which features pure sine wave models equipped with advanced power control and inverter assist functions for efficient...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.